Blood test for a toxic protein may detect CTE
A NewsNation report says a blood test developed to track abnormal tau in Alzheimer's disease also picked up the toxic protein in people with advanced CTE, offering a hint the test may one day help diagnose the brain disease in football players and others with repeated head trauma. CTE can now only be confirmed by examining the brain after death, since other diseases mimic its symptoms. Washington University in St. Louis researchers found high levels of the eMTBR-tau243 biomarker in stored blood from people with advanced CTE, but reported the biomarker could not reliably identify early-stage CTE.
Studies: Blood test has potential to detect CTE in the living
Two new studies published in JAMA suggest a blood test shows potential to detect advanced stages of chronic traumatic encephalopathy in the living, a degenerative brain disease linked to repeated head blows that until now could be diagnosed only after death. In the larger study, researchers at Boston University and Banner Health examined 21 deceased football players who had donated blood while alive, and the level of a specific protein in those samples matched the advanced CTE that autopsies later confirmed; a separate Washington University School of Medicine study based on 11 cases identified the same biomarker. The test showed promise only for advanced stages, which bring symptoms like memory loss and severe mood swings, not the symptom-free early ones, and co-senior author Michael Alosco, who calls it a game changer, cautions the sample is small and the work is still in the discovery phase. ESPN reports that a possible test raises hard questions for players, some of whom, like Marcus Mariota, would take one, while others, like Joshua Metellus, would not want to know while still playing.
Scientists Discover a Possible Marker in the Blood of C.T.E. Patients
Two studies published in JAMA describe related blood markers of C.T.E., the incurable brain disease tied to repeated head blows, and researchers hope the findings lead to a commercially available blood test within five years. Until now C.T.E. could only be confirmed by brain autopsy after death, so a test for the living would end agonizing uncertainty for patients and families and could draw drug developers to the field. One Washington University team chanced on the marker, a tau protein fragment, while testing brain disease samples, and found higher levels in people with more advanced C.T.E.; the other, from the CTE Research Center at Boston University, found similarly elevated levels in 21 former football players, with a clear separation between high-stage cases and the rest. The studies were small, and researchers and outside experts like Dr. Julian Bailes and Marc Weisskopf say the biomarker needs verification in larger samples and remains at best a research tool for now.
Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology
A JAMA original investigation reports that plasma eMTBR-tau, a blood biomarker of tau tangle pathology, is significantly higher in former football players who had chronic traumatic encephalopathy than in those without it, and rises with CTE stage, with the highest concentrations in participants who also had Alzheimer disease neuropathologic change. In the case series of 21 male former football brain donors, high-stage CTE participants had markedly higher levels than those with low-stage or no CTE, while the established marker p-tau217 was not associated with CTE and instead tracked amyloid and Alzheimer pathology. The authors conclude that eMTBR-tau may represent a feasible biomarker for high-stage CTE, which matters because no validated biomarker currently allows CTE to be diagnosed during life, and they suggest that elevated eMTBR-tau with a negative p-tau217 result could point to CTE without Alzheimer disease. They caution that the small convenience sample of football players limits generalizability and that larger autopsy and clinical validation studies are needed to establish diagnostic accuracy and specificity.
New Blood Test May Be Able To Detect CTE In The Living
A HuffPost live-updates page leads with two recent studies suggesting a new blood test may detect chronic traumatic encephalopathy, a brain disease linked to football and other contact sports, in the living for the first time. CTE has so far only been detectable after a person has died. Researchers identified a specific protein, a marker of the disease, in blood samples collected from former football players. Michael Alosco, co-director of clinical research at Boston University's CTE Center, cautions the work is still in the discovery phase with a small sample size, but says validated findings would allow detection with a high level of accuracy and open the doors to clinical trials and treatment.
